
Marina Boix CastejónUniversidad Miguel Hernández de Elche | UMH · Institute of Bioengineering
Marina Boix Castejón
PhD Student
About
7
Publications
1,399
Reads
How we measure 'reads'
A 'read' is counted each time someone views a publication summary (such as the title, abstract, and list of authors), clicks on a figure, or views or downloads the full-text. Learn more
96
Citations
Citations since 2017
Publications
Publications (7)
Many patients with stage 1 hypertension have difficulties to achieve lifestyle changes to avoid the progression of the disease. The use of natural alternatives with demonstrated blood pressure-regulating properties is instrumental at this stage, avoiding the side effects found in some pharmaceutical drugs. In this context, previous studies have ind...
The aim of the present report was to evaluate the inflammatory response to a 2000-m running test considering neutrophil myeloperoxidase as an inflammatory marker, and to verify if supplements rich in antioxidants could modulate Post-test antioxidant and anti-inflammatory responses. To this end, a 21-day homogenization period was carried out with th...
Plant-polyphenols have shown the capacity to ameliorate obesity-induced metabolic disturbances, both in cell and animal models, where most therapeutic approaches have failed. On the basis of previous research, a dietary supplement containing 500mg of a combination of polyphenolic extracts from Lippia citriodora L. and Hibiscus sabdarifa L. (LC-HS),...
Correction for ‘Hibiscus and lemon verbena polyphenols modulate appetite-related biomarkers in overweight subjects: a randomized controlled trial’ by Marina Boix-Castejón et al. , Food Funct. , 2018, 9 , 3173–3184.
Trial design:
Plant-derived polyphenols have shown potential to alleviate obesity-related pathologies by a multi-targeted mechanism in animal models and human intervention studies. A dietary supplement based on a combination of Lippia citriodora (LC) and Hibiscus sabdariffa (HS) polyphenolic extracts was assayed in a double blind and placebo-contr...
Obesity is one of the most pervasive in chronic diseases where therapeutic approaches have failed. Emerging scientific evidence indicates that dietary supplementation may be an alternative in the treatment of obesity and other metabolic disorders.
A previous study showed that the consumption of 500 mg/day of MetabolAid® dietary ingredient (Lippia c...